Company
We’re a biopharmaceutical company developing innovative prescription medicines.
Our Vision
Our goal is to improve the lives of those affected by the burden of chronic respiratory diseases. We are committed to delivering our treatments to the millions of patients suffering from respiratory diseases as quickly as possible.
Our Strategy
We are focused on developing ensifentrine, which we believe has the potential to become an important and novel treatment for lung diseases.
Company Leadership
We expect 2024 to be a transformational year for Verona Pharma. We are finalizing our US launch preparations and look forward to commercializing OhtuvayreTM (ensifentrine) in the third quarter of this year. We will also continue to progress our development programs to build-out our pipeline.
Careers
We are expanding rapidly and seeking exceptional people to join our team. Explore career opportunities at Verona.
Verona’s Board of Directors sets high standards for our employees, officers and directors and good corporate governance is implicit in these values. Learn more here.
To learn more about Verona Pharma, please get in touch.